PATENT CLAIM ANALYSIS

Application Number: 16116426
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "218100"]

Abstract:
In one embodiment, the present invention is a method of treating glioma and medulloblastoma brain tumors using the Zika virus and a tumor vaccine.

Claim (Index 7):
The anti-tumor composition of  claim 6 , wherein the vaccine is comprised of irradiated allogeneic GBM tumor cells previously infected with the Zika virus, and wherein the vaccine is administered with the cytokine GM-CSF.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 96.0
- Lexical Diversity: 1.13043
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15037774', '14254235', '16068826', '14416754', '09875349']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6836962675620742
- 35 USC 102 Novelty (BERT): 0.5260484611873452
- Combined Prediction Score: 0.6679314869246014
- Mean Citation Score: 270.50809200000003
- Max Citation Score: 309.7225
- Similarity Product: 203.51223712101583

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test